ArticlePLoS pathogens2022

CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection.

Mary S Pampusch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.